{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:59:42Z","timestamp":1793145582948,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T00:00:00Z","timestamp":1506211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T00:00:00Z","timestamp":1506211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/bjd.15454","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T18:37:14Z","timestamp":1489516634000},"page":"1093-1101","source":"Crossref","is-referenced-by-count":76,"title":["Analysis of disease activity categories in chronic spontaneous\/idiopathic urticaria"],"prefix":"10.1093","volume":"177","author":[{"given":"D.","family":"Stull","sequence":"first","affiliation":[{"name":"RTI Health Solutions; 200 Park Offices Drive, PO Box 12194 Research Triangle Park NC 27709-2194 U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-651X","authenticated-orcid":false,"given":"D.","family":"McBride","sequence":"additional","affiliation":[{"name":"RTI Health Solutions; The Pavilion, Towers Business Park, Wilmslow Road, Didsbury Manchester M20 2LS U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tian","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation; East Hanover NJ U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gimenez Arnau","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital del Mar and Universitat Aut\u00f2noma; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy; Allergie-Centrum-Charit\u00e9; Charit\u00e9-Universit\u00e4tsmedizin Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marsland","sequence":"additional","affiliation":[{"name":"Dermatology Department; Salford Royal Hospital and University of Manchester; Manchester U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-M.","family":"Balp","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG; GMA & HEOR; Novartis Campus Basel 4056 Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khalil","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG; GMA & HEOR; Novartis Campus Basel 4056 Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grattan","sequence":"additional","affiliation":[{"name":"Cutaneous Allergy; Guy's Hospital; London U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,24]]},"reference":[{"key":"10.1111\/bjd.15454-BIB0001|bjd15454-cit-0001","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA2LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1111\/bjd.15454-BIB0002|bjd15454-cit-0002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O'Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15454-BIB0003|bjd15454-cit-0003","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","article-title":"Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity","volume":"154","author":"Staubach","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15454-BIB0004|bjd15454-cit-0004","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archdermatol.2011.310","article-title":"Chronic spontaneous urticaria - how to assess quality of life in patients on treatment","volume":"147","author":"Weller","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15454-BIB0005|bjd15454-cit-0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","article-title":"How to assess disease activity in patients with chronic urticaria?","volume":"63","author":"Mynek","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/bjd.15454-BIB0006|bjd15454-cit-0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anai.2010.06.011","article-title":"Development of a daily diary for patients with chronic idiopathic urticaria","volume":"105","author":"Mathias","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/bjd.15454-BIB0007|bjd15454-cit-0007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.15454-BIB0008|bjd15454-cit-0008","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","article-title":"A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-Q2oL)","volume":"60","author":"Baiardini","year":"2005","journal-title":"Allergy"},{"key":"10.1111\/bjd.15454-BIB0009|bjd15454-cit-0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","article-title":"Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study","volume":"135","author":"Saini","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15454-BIB0010|bjd15454-cit-0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.15454-BIB0011|bjd15454-cit-0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15454-BIB0012|bjd15454-cit-0012","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"10.1111\/bjd.15454-BIB0013|bjd15454-cit-0013","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40271-013-0021-4","article-title":"Demonstrating measurement equivalence of the electronic and paper formats of the Urticaria Patient Daily Diary in patients with chronic idiopathic urticaria","volume":"6","author":"Flood","year":"2013","journal-title":"Patient"},{"key":"10.1111\/bjd.15454-BIB0014|bjd15454-cit-0014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1081-1206(10)61466-4","article-title":"Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life","volume":"93","author":"Lennox","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/bjd.15454-BIB0015|bjd15454-cit-0015","doi-asserted-by":"crossref","first-page":"AB131","DOI":"10.1016\/j.jaci.2014.12.1362","article-title":"Weekly Urticaria Activity Score (UAS7) and Dermatology Life Quality Index (DLQI) in validation of chronic spontaneous urticaria (CSU\/CIU) health states","volume":"135","author":"Khalil","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.15454-BIB0016|bjd15454-cit-0016","unstructured":"National Institute for Health and Care Excellence NICE Technology Appraisal Guidance 339. Omalizumab for previously treated chronic spontaneous urticaria https:\/\/www.nice.org.uk\/guidance\/ta339"},{"key":"10.1111\/bjd.15454-BIB0017|bjd15454-cit-0017","article-title":"Evaluating the severity in chronic spontaneous urticaria patients treated with rupatadine by means a recent categorized health states classification of urticaria activity score","author":"Giralt","journal-title":"EAACI Online Library"},{"key":"10.1111\/bjd.15454-BIB0018|bjd15454-cit-0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-3-36","article-title":"Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria","volume":"3","author":"Shikiar","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/bjd.15454-BIB0019|bjd15454-cit-0019","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15454-BIB0020|bjd15454-cit-0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1398-9995.2011.02580.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: A GA\u00b2LEN taskforce position paper","volume":"66","author":"Baiardini","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/bjd.15454-BIB0021|bjd15454-cit-0021","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12325-016-0282-0","article-title":"Assessing changes in chronic spontaneous\/idiopathic urticaria: comparisons of patient-reported outcomes using latent growth modeling","volume":"33","author":"Stull","year":"2016","journal-title":"Adv Ther"},{"key":"10.1111\/bjd.15454-BIB0022|bjd15454-cit-0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2133.2006.07736.x","article-title":"Itch Severity Scale: a self-report instrument for the measurement of pruritus severity","volume":"156","author":"Majeski","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15454-BIB0023|bjd15454-cit-0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/jid.2011.354","article-title":"Dermatology Life Quality Index: time to move forward","volume":"132","author":"Nijsten","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15454-BIB0024|bjd15454-cit-0024","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.15454-BIB0025|bjd15454-cit-0025","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2012.147","article-title":"DLQI: a paradigm shift to patient-centred outcomes","volume":"132","author":"Finlay","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.15454-BIB0026|bjd15454-cit-0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15454","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15454\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:26:15Z","timestamp":1676384775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/177\/4\/1093\/6674046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,24]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15454","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,24]]}}}